Eman Nossier | Pharmaceutical Medicinal Chemistry | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Eman Nossier |Pharmaceutical Medicinal ChemistryĀ  | Best Researcher Award

 

šŸŒŸ Profile Summary

šŸŽ“ As an accomplished pharmaceutical scientist, I hold a Ph.D. in Pharmaceutical Chemistry (2014) and have been an integral part of Al-Azhar University’s Faculty of Pharmacy since 2012. Currently serving as an Associate Professor, I specialize in Pharmaceutical Medicinal Chemistry & Drug Design. šŸ« My responsibilities include teaching courses like Pharmaceutical Chemistry I and II, as well as guiding postgraduate students.

šŸ‘©ā€šŸ« With a rich educational background, including a Master’s in Pharmaceutical Sciences (2009) and a Bachelor’s in Pharmacy (2002), I have contributed significantly to the academic and research domains. šŸ’Š My prior experience at the National Research Center, focusing on Therapeutic Chemistry, has further enriched my expertise.

šŸ’” Engaging in various activities such as Chemoffice and Scifinder, I continuously strive for excellence. My commitment extends beyond teaching to include supervising practical courses and fostering the academic growth of aspiring pharmaceutical professionals. šŸŒ

 

šŸŒ Professional Profiles

šŸŽ“Qualifications

PhD in Pharmaceutical Science with a focus on Pharmaceutical Chemistry (2014) MSc in Pharmaceutical Science with a specialization in Pharmaceutical Chemistry (2009) BSc in Pharmaceutical Science from Al-Azhar University (2002)

šŸ’¼Work Experience

 

Associate Professor of Pharmaceutical Chemistry (2019 – Present) Ā Main Responsibilities: Teaching courses: Pharmaceutical Chemistry I, Pharmaceutical Chemistry II Supervision of postgraduate students Lecturer of Pharmaceutical Chemistry (2014 – 2019) Ā Main Responsibilities: Teaching courses: Pharmaceutical Chemistry I, Pharmaceutical Chemistry II Supervision of practical courses Supervision of postgraduate students Assistant Lecturer of Pharmaceutical Chemistry (2012 – 2014) Ā Main Responsibilities: Supervision and teaching of practical courses Participation in practical exams Preparing to obtain the PhD degree National Research Center, Pharmaceutical and Drug Industries Division, Therapeutic Chemistry Department: Pharmacist (2003-2006) Researcher Assistant (2006-2009) Assistant Researcher (2009-2012)

šŸ“šEducation History

Doctor of Philosophy (Ph.D.) in Pharmaceutical Chemistry, Al-Azhar University (Girls)- Cairo, Egypt (2014) Master in Pharmaceutical Sciences (Pharmaceutical Chemistry), Al-Azhar University (Girls)- Cairo, Egypt (2009) Bachelor of Pharmacy, Al-Azhar University – Cairo, Egypt (2002)

Other Activities

Proficient in Chemoffice 2016, Scifinder, and Molsoft ICM 3.4-8C program. Ā Completed a Training Course of “Occupational Safety and Health” at Training and Skills Development Center, National Research Centre (Egypt, January 17-21, 2004). Ā Completed a Training Course of “Scientific Writing” at Training and Skills Development Center, National Research Centre (Egypt, May 24-June 2, 2004). Ā Passed the International Computer Driving Licence Exam (ICDL) in 2010. Ā Participation in organizing the 3rd International Conference of Pharmaceutical and Drug Industries Division, National Research Centre under the theme of Research and Development in Drugs (Future Trends) (March 6-8, 2007). Ā Participation as a speaker in the 4th International Conference of Pharmaceutical and Drug Industries Division, National Research Centre under the theme of Research and Development in Drugs (Current Challenges) (March 3-5, 2009). Ā Completed a Training Course of “Computer-aided Drug Design Using MOE Software” at Medicinal Chemistry Department, Faculty of Pharmacy, Assiut University (Egypt, January 26-28, 2013). Ā Participation as a poster presenter in the 5th International Chemistry Conference under the theme “Chemistry for Durable Globe and Society Welfare,” Abha, Saudi Arabia (April 26-29, 2014). Ā Completed a Training Course of “Structure-Based, Ligand-Based Drug Design Using Discovery Studio Software” at Professional Development Program, Faculty of Pharmacy, Misr International University (Egypt, September 2014).

šŸ†Awards

The Best Poster Award at the 4th International Conference on New Horizons in Basic and Applied Sciences (ICNHBAS2019), Faculty of Science, Al-Azhar University, Assuit, Egypt (July 26-29, 2019).Ā The Best Poster Award at the 15th International Conference on Chemistry and its Role in Development (ICCRD ’15), Faculty of Science, Mansoura University, Hurghada, Egypt (August 9-13, 2021).Ā The Best Scientific Production Award at the Faculty of Pharmacy (Girls), Al-Azhar University (2021-2022).

Membership in Scientific Societies

Member of The Egyptian Chemical Society. Member of the Arab Association of Pharmacy Progress. Member of The National Committee of Drugs by the Academy of Scientific Research and Technology (ASRT) for the term 2022-2025. Member of The Organization for Women in Science for the Developing World (OWSD), Trieste, Italy.

Reviewer in Scientific Journals

Reviewer for the Journal of Enzyme Inhibition and Medicinal Chemistry. Reviewer for Springer Nature Applied Sciences. Ā Reviewer for Breast Cancer: Targets and Therapy. Reviewer for Synthetic Communications. Reviewer for the Journal of Molecular Structure Reviewer for the Egyptian Journal of Chemistry. Reviewer for the Egyptian Pharmaceutical Journal. Reviewer for Molecules. Reviewer for Future Medicinal Chemistry.

šŸ§ŖResearch Projects Involvement

Member in project No. 7020103: “Anti-inflammatory agents: new derivatives as cyclooxygenase inhibitors” Funded by NRC, Cairo, Egypt (2004-2007). Member in project No. 9100102: “Oriented synthesis & pharmacological evaluation of novel organic compounds as anticancer agents” Funded by NRC, Cairo, Egypt (2010-2013). Ā Member in project No. P100208: “Synthesis, molecular modeling studies and biological evaluation of novel pyrazole derivatives as antitumor and EGFR inhibitor” Funded by NRC, Cairo, Egypt (2015-2016). Ā Member in project No. P100205: “Oriented synthesis and anticancer evaluation of new organic compounds” Funded by NRC, Cairo, Egypt (2015-2016). Ā Member in project No. 11010312: “Oriented Synthesis and Molecular Modeling Studies of Novel Heterocyclic Derivatives Including Quinazoline, Pyrazole, benzimidazole and/or Pyrimidine Moieties of Expected Anti-Neoplastic Activity” Funded by NRC, Cairo, Egypt (2016-2019). Ā Member in project No. 11010315: “Synthesis and Molecular Modeling of Some Thiopyrimidine-5-carbonitrile Derivatives as Anticancer and Antimicrobial Agents” Funded by NRC, Cairo, Egypt (2016-2019). Ā Member in project No. 12060111: “Oriented synthesis and molecular modeling studies of novel derivatives including different heterocyclic moieties of expected anti-inflammatory, antihypertension, and anticancer activities” Funded by NRC, Cairo, Egypt (2019-2022). Ā Member in project No. 10191-cos-2020-1-3-I: “Design, Synthesis, Anticancer Activity and Molecular Modeling of New Hybrids Containing Triazole and Derived Glycosides” Funded by Qassim University, Qassim, Saudi Arabia (2020-2022). Ā Member in project No. 43327: “Design, synthesis, and anti-cancer evaluation of new pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as potential EGFRWT and EGFRT790M inhibitors and apoptosis inducers” Funded by Science and Technology Development Fund (STDF), Cairo, Egypt (2020-2021). Ā Member in project No. IFPIP: 210-247-1442: “Design, Synthesis, Anticancer Evaluation and Molecular Docking of Novel Thiophene-based derivatives” Funded by King Abdulaziz University, Jeddah, Saudi Arabia (2021-2022). Ā Member in project No. IFPIP: 1237-247-1443: “Synthesis, bioevaluation, and in silico studies of novel pyridine and pyrazole derivatives as selective c-Met kinase inhibitors of potential anticancer activity” Funded by King Abdulaziz University, Jeddah, Saudi Arabia (2022-2023).

šŸ“šTop Noted Publication

Antibacterial evaluation, in silico characters and molecular docking of Schiff bases derived from 5-aminopyrazoles Paper Published in 2017 Cited by 67

 

Design, synthesis, anticancer evaluation, enzymatic assays, and a molecular modeling study of novel pyrazoleā€“indole hybrids Paper Published in 2021 Cited by 65

 

New pyrimidine and pyrazole-based compounds as potential EGFR inhibitors: Synthesis, anticancer, antimicrobial evaluation and computational studies Paper Published in 2021 Cited by 58

 

Design and synthesis of novel pyrazole-substituted different nitrogenous heterocyclic ring systems as potential anti-inflammatory agents Paper Published in 2017 Cited by 57

 

Design, synthesis and molecular docking of new pyrazole-thiazolidinones as potent anti-inflammatory and analgesic agents with TNF-Ī± inhibitory activity Paper Published in 2021Cited by 54

 

Synthesis and molecular docking study of new pyrazole derivatives as potent anti-breast cancer agents targeting VEGFR-2 kinase Paper Published in 2020 Cited by 54

 

Click chemistry based synthesis, cytotoxic activity and molecular docking of novel triazole-thienopyrimidine hybrid glycosides targeting EGFR Paper Published in 2021 Cited by 51

 

Novel phthalimide based analogues: Design, synthesis, biological evaluation, and molecular docking studies Paper Published in 1019 Cited by48

 

Biological Validation of Novel Polysubstituted Pyrazole Candidates withĀ in Vitro Anticancer Activities Paper Published in 2016 Cited by 48